Botanical species · safety record

Aconitum lycoctonum

The EFSA Compendium of Botanicals holds 3 constituent measurements for Aconitum lycoctonum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Aconitum lycoctonum L.

3Constituent measurements
0Safety records
2Cited sources
3Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 3 licensed products naming Aconitum lycoctonum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Whole plant(s)

What the records describe

Constituents measured

  • Alkaloids1
  • Gigactonine1
  • Lycoctonine1

Plant parts

  • Flower2
  • Roots and other underground parts1

Preparations

  • Solvent extraction3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
GigactonineFlowerSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
LycoctonineFlowerSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
AlkaloidsRoots and other underground partsSolvent extraction2.47 PercentStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Chen, Y., Katz, A. Isolation of norditerpenoid alkaloids from flowers of Aconitum lycoctonum . Journal of natural products, 1999, vol. 62, no. 5, p. 798-799. DOI
  2. Villar del Fresno, A., Cabo Torres, J. Phytochemical study of Aconitum lycoctonum from Sierra Nevada. I. Determination of its alkaloid content.. Ars pharmaceutica, 1970, vol. 11, no. 11-12, p. 551-4.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue